S&P 500   4,584.61 (+1.02%)
DOW   35,201.68 (+1.80%)
QQQ   383.81 (+0.18%)
AAPL   165.81 (+2.45%)
MSFT   322.78 (-0.07%)
FB   314.92 (+2.63%)
GOOGL   2,839.08 (-0.03%)
AMZN   3,413.67 (+0.70%)
TSLA   983.77 (-3.07%)
NVDA   293.47 (-4.39%)
BABA   120.07 (+7.24%)
NIO   32.08 (-0.22%)
CGC   10.02 (+0.30%)
AMD   136.12 (-5.48%)
GE   96.24 (+3.74%)
MU   81.86 (+0.29%)
T   23.72 (+1.11%)
F   19.25 (+0.57%)
DIS   150.54 (+2.95%)
PFE   52.29 (-3.65%)
AMC   28.89 (-0.41%)
ACB   5.89 (+1.20%)
BA   205.82 (+3.69%)
S&P 500   4,584.61 (+1.02%)
DOW   35,201.68 (+1.80%)
QQQ   383.81 (+0.18%)
AAPL   165.81 (+2.45%)
MSFT   322.78 (-0.07%)
FB   314.92 (+2.63%)
GOOGL   2,839.08 (-0.03%)
AMZN   3,413.67 (+0.70%)
TSLA   983.77 (-3.07%)
NVDA   293.47 (-4.39%)
BABA   120.07 (+7.24%)
NIO   32.08 (-0.22%)
CGC   10.02 (+0.30%)
AMD   136.12 (-5.48%)
GE   96.24 (+3.74%)
MU   81.86 (+0.29%)
T   23.72 (+1.11%)
F   19.25 (+0.57%)
DIS   150.54 (+2.95%)
PFE   52.29 (-3.65%)
AMC   28.89 (-0.41%)
ACB   5.89 (+1.20%)
BA   205.82 (+3.69%)
S&P 500   4,584.61 (+1.02%)
DOW   35,201.68 (+1.80%)
QQQ   383.81 (+0.18%)
AAPL   165.81 (+2.45%)
MSFT   322.78 (-0.07%)
FB   314.92 (+2.63%)
GOOGL   2,839.08 (-0.03%)
AMZN   3,413.67 (+0.70%)
TSLA   983.77 (-3.07%)
NVDA   293.47 (-4.39%)
BABA   120.07 (+7.24%)
NIO   32.08 (-0.22%)
CGC   10.02 (+0.30%)
AMD   136.12 (-5.48%)
GE   96.24 (+3.74%)
MU   81.86 (+0.29%)
T   23.72 (+1.11%)
F   19.25 (+0.57%)
DIS   150.54 (+2.95%)
PFE   52.29 (-3.65%)
AMC   28.89 (-0.41%)
ACB   5.89 (+1.20%)
BA   205.82 (+3.69%)
S&P 500   4,584.61 (+1.02%)
DOW   35,201.68 (+1.80%)
QQQ   383.81 (+0.18%)
AAPL   165.81 (+2.45%)
MSFT   322.78 (-0.07%)
FB   314.92 (+2.63%)
GOOGL   2,839.08 (-0.03%)
AMZN   3,413.67 (+0.70%)
TSLA   983.77 (-3.07%)
NVDA   293.47 (-4.39%)
BABA   120.07 (+7.24%)
NIO   32.08 (-0.22%)
CGC   10.02 (+0.30%)
AMD   136.12 (-5.48%)
GE   96.24 (+3.74%)
MU   81.86 (+0.29%)
T   23.72 (+1.11%)
F   19.25 (+0.57%)
DIS   150.54 (+2.95%)
PFE   52.29 (-3.65%)
AMC   28.89 (-0.41%)
ACB   5.89 (+1.20%)
BA   205.82 (+3.69%)
OTCMKTS:RDGL

Vivos News Headlines

$0.08
-0.01 (-11.83%)
(As of 12/3/2021 03:58 PM ET)
Add
Compare
Today's Range
$0.07
$0.09
50-Day Range
$0.08
$0.12
52-Week Range
$0.05
$0.31
Volume
972,000 shs
Average Volume
852,391 shs
Market Capitalization
$26.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.35

Media Mentions By Week



Vivos Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RDGL
News Sentiment

0.73

0.48

Average
Finance
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RDGL Articles
This Week

1

0

RDGL Articles
Average Week

Get Vivos News Delivered to You Automatically

Sign up to receive the latest news and ratings for RDGL and its competitors with MarketBeat's FREE daily newsletter.

Vivos (OTCMKTS:RDGL) News Headlines Today

SourceHeadline
finance.yahoo.com logoVivos Inc Obtains Feedback from the FDA on Clinical Testing of RadioGel™
finance.yahoo.com - December 2 at 11:50 AM
MarketBeat logoVivos Inc. (OTCMKTS:RDGL) Short Interest Update
americanbankingnews.com - November 29 at 9:36 AM
MarketBeat logoVivos (RDGL) & Its Competitors Critical Analysis
americanbankingnews.com - November 24 at 11:14 AM
finance.yahoo.com logoVivos Inc Announces Johns Hopkins University (Veterinary Clinical Trials Network) is a New Regional Clinic for Isopet®
finance.yahoo.com - November 23 at 2:04 PM
finance.yahoo.com logoVivos Inc Announces John Hopkins University as a New Regional Clinic for Isopet®
finance.yahoo.com - November 22 at 2:28 PM
MarketBeat logoShort Interest in Vivos Inc. (OTCMKTS:RDGL) Rises By 2,326.1%
americanbankingnews.com - November 15 at 11:32 AM
finance.yahoo.com logoVivos Inc. Files Early Feasibility IDE Application with FDA for Radiogel™
finance.yahoo.com - September 20 at 1:03 PM
finance.yahoo.com logoVivos Inc Initiates Isopet® Therapy in Horses
finance.yahoo.com - June 24 at 12:51 PM
finance.yahoo.com logoVivos Inc. Expands IsoPet® Trademark Protection
finance.yahoo.com - May 27 at 1:02 PM
ca.finance.yahoo.com logoApple Rush Company, Inc. partner, Botanaway, Inc. featured in May 16th article in Cannabis Now magazine
ca.finance.yahoo.com - May 26 at 1:05 AM
finance.yahoo.com logoVivos Inc Enhances Radiogel™ Manufacturing Process
finance.yahoo.com - May 24 at 12:20 PM
finance.yahoo.com logoVivos Inc. Provides 2020 Recap and Outlines 2021 Objectives
finance.yahoo.com - January 28 at 10:08 AM
finance.yahoo.com logoVivos Inc Receives Feedback from FDA on Breakthrough Designation Request
finance.yahoo.com - January 19 at 6:56 PM
markets.businessinsider.com logoNews for Vivos Inc Registered Shs
markets.businessinsider.com - January 15 at 2:36 PM
bloomberg.com logoVivos Inc
bloomberg.com - December 19 at 11:59 PM
finance.yahoo.com logoVivos Inc Completes Surrogate Lymph Node Testing Using Mouse Spleen Injections Demonstrating Uniform Perfusion and Stability
finance.yahoo.com - December 9 at 5:02 PM
finance.yahoo.com logoVivos Inc to Present at The LD 500 Virtual Conference
finance.yahoo.com - December 7 at 4:45 PM
finance.yahoo.com logoVivos Inc Initiates IsoPet Therapy of Horses – Addressing Unmet Need for the Treatment of Equine Tumors
finance.yahoo.com - December 7 at 4:45 PM
finance.yahoo.com logoVivos Inc Applies for Breakthrough Device Designation for Radiogel™
finance.yahoo.com - December 7 at 4:45 PM
finance.yahoo.com logoVivos Inc Extends it Intellectual Property Protection
finance.yahoo.com - December 7 at 4:45 PM
finance.yahoo.com logoVivos Inc to Present at The 13th Annual LD Micro Main Event Conference December 15, 2020 11:00 AM Eastern Standard Time
finance.yahoo.com - December 7 at 4:45 PM
www.latimes.com logoNFL's Matt Kalil flips Pasadena estate for a profit
www.latimes.com - June 1 at 1:40 PM
feeds.benzinga.com logoPuration Posts Q1 Results, Touts 173% Revenue Spike
feeds.benzinga.com - May 21 at 2:58 PM
finance.yahoo.com logoExclusive: Trial of Gilead's potential coronavirus treatment running ahead of schedule, researcher says
finance.yahoo.com - April 24 at 3:05 PM
www.latimes.com logoUSC standout Matt Kalil scores a two-acre property in Pasadena
www.latimes.com - April 7 at 3:27 PM
feeds.reuters.com logoSilver lining? Russia's Cossacks don modified masks against coronavirus
feeds.reuters.com - April 3 at 10:51 AM
www.latimes.com logoHot Property: Mindy Kaling makes a splash on Malibu's Broad Beach
www.latimes.com - March 7 at 12:50 PM
Get Vivos News Delivered to You Automatically

Sign up to receive the latest news and ratings for RDGL and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.